Rapid clearance of mepolizumab-resistant bronchial mucus plugs in allergic bronchopulmonary aspergillosis with benralizumab treatment
Open Access
- 1 April 2020
- journal article
- letter
- Published by Elsevier BV in Allergology International
- Vol. 69 (4), 636-638
- https://doi.org/10.1016/j.alit.2020.03.003
Abstract
No abstract availableFunding Information
- Japan Agency for Medical Research and Development (19ek0410055)
This publication has 9 references indexed in Scilit:
- Allergic bronchopulmonary aspergillosis successfully treated with benralizumabThe Journal of Allergy and Clinical Immunology: In Practice, 2018
- A case of allergic bronchopulmonary aspergillosis successfully treated with mepolizumabBMC Pulmonary Medicine, 2018
- Allergic bronchopulmonary aspergillosis in Japan: A nationwide surveyAllergology International, 2018
- Eosinophilic Otitis Media: the Aftermath of Eosinophil Extracellular Trap Cell DeathCurrent Allergy and Asthma Reports, 2017
- Pulmonary Nontuberculous Mycobacteriosis and Chronic Lower Respiratory Tract Infections in Patients with Allergic Bronchopulmonary Mycosis without Cystic FibrosisInternal Medicine, 2016
- Effects of benralizumab on airway eosinophils in asthmatic patients with sputum eosinophiliaJournal of Allergy and Clinical Immunology, 2013
- Eosinophil extracellular DNA trap cell death mediates lytic release of free secretion-competent eosinophil granules in humansBlood, 2013
- MEDI-563, a humanized anti–IL-5 receptor α mAb with enhanced antibody-dependent cell-mediated cytotoxicity functionJournal of Allergy and Clinical Immunology, 2010
- Mepolizumab and Exacerbations of Refractory Eosinophilic AsthmaThe New England Journal of Medicine, 2009